NO902411L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.Info
- Publication number
- NO902411L NO902411L NO90902411A NO902411A NO902411L NO 902411 L NO902411 L NO 902411L NO 90902411 A NO90902411 A NO 90902411A NO 902411 A NO902411 A NO 902411A NO 902411 L NO902411 L NO 902411L
- Authority
- NO
- Norway
- Prior art keywords
- group
- formula
- bond
- propylamines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3917801A DE3917801A1 (de) | 1989-06-01 | 1989-06-01 | 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE3934436A DE3934436A1 (de) | 1989-06-01 | 1989-10-14 | 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO902411D0 NO902411D0 (no) | 1990-05-31 |
| NO902411L true NO902411L (no) | 1990-12-03 |
Family
ID=25881458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90902411A NO902411L (no) | 1989-06-01 | 1990-05-31 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5135932A (fr) |
| EP (1) | EP0400519A1 (fr) |
| JP (1) | JPH03236378A (fr) |
| KR (1) | KR910000660A (fr) |
| AU (1) | AU623262B2 (fr) |
| CA (1) | CA2017957A1 (fr) |
| DE (1) | DE3934436A1 (fr) |
| FI (1) | FI902734A7 (fr) |
| HU (1) | HU206201B (fr) |
| IL (1) | IL94556A0 (fr) |
| NO (1) | NO902411L (fr) |
| NZ (1) | NZ233875A (fr) |
| PT (1) | PT94213A (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5221674A (en) * | 1989-06-19 | 1993-06-22 | Teikoku Hormone Mfg. Co., Ltd. | Pyridazinone derivatives |
| HU209388B (en) * | 1990-12-27 | 1994-05-30 | Richter Gedeon Vegyeszet | Process for producing new 3/2h/-pyridazinones and pharmaceutical compositions comprising same |
| DE4237656A1 (de) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | Benzimidazolderivate |
| US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| DK1005460T3 (da) * | 1997-08-22 | 2006-07-10 | Abbott Lab | Inhibitorer af biosyntesen af prostaglandin-endoperoxid H-synthase |
| KR100489649B1 (ko) * | 1998-04-14 | 2005-09-02 | 삼성정밀화학 주식회사 | (s)-3-치환-2-히드록시프로필아민의제조방법 |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| CN1469876A (zh) * | 2000-10-20 | 2004-01-21 | �Ʒ� | α-芳基乙醇胺及其用作β-3肾上腺素能受体激动剂的用途 |
| US7709677B2 (en) * | 2001-01-31 | 2010-05-04 | Glaxosmithkline Llc | Process of preparing arylethanoldiamines |
| GB0102407D0 (en) | 2001-01-31 | 2001-03-14 | Glaxo Group Ltd | Process |
| WO2003072547A1 (fr) | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | Procedes et intermediaires utiles dans la preparation d'agonistes du recepteur $g(b)3 adrenergique |
| WO2003072573A1 (fr) * | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | Formes cristallines de (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| AU2003297562A1 (en) * | 2002-11-27 | 2004-06-23 | Artesian Therapeutics, Inc. | COMPOUNDS WITH MIXED PDE-INHIBITORY AND Beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| US20070117978A1 (en) * | 2002-12-23 | 2007-05-24 | Artesian Therapecutics, Inc | Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| US20050075323A1 (en) * | 2003-03-05 | 2005-04-07 | Pfizer Inc | Beta3 adrenergic receptor agonists and uses thereof |
| US20080090827A1 (en) * | 2004-11-30 | 2008-04-17 | Artesian Therapeutics, Inc. | Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| EP1833480A2 (fr) * | 2004-11-30 | 2007-09-19 | Artesian Therapeutics, Inc. | Composes cardiotoniques dotes d'une activite inhibitrice dirigee contre les recepteurs beta-adrenergiques et la phosphodiesterase |
| HRP20130044T1 (hr) | 2006-07-25 | 2013-02-28 | Cephalon, Inc. | Derivati piridizinona |
| US20130261178A1 (en) | 2010-07-05 | 2013-10-03 | Shailesh Mistry | Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases |
| US9522129B2 (en) | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| GB201101959D0 (en) * | 2011-02-04 | 2011-03-23 | Univ Nottingham | Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease |
| HK1245117A1 (zh) | 2014-12-03 | 2018-08-24 | Velicept Therapeutics, Inc. | 使用调节释放索拉贝隆用於下尿路症状的组合物和方法 |
| ES2967863T3 (es) | 2015-10-23 | 2024-05-06 | B3Ar Therapeutics Inc | Ion dipolar de solabegron y usos del mismo |
| WO2018086703A1 (fr) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituées par des phénylurées |
| EP3746079A1 (fr) | 2018-01-31 | 2020-12-09 | Bayer Aktiengesellschaft | Conjugués anticorps-médicament (adc) avec des inhibiteurs de nampt |
| WO2021013693A1 (fr) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Conjugués anticorps-médicament (adc) avec des inhibiteurs de nampt |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
| ES8101067A1 (es) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
| DE3023369A1 (de) * | 1980-06-23 | 1982-01-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3129447A1 (de) * | 1981-07-25 | 1983-02-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel" |
| GB8323553D0 (en) * | 1983-09-02 | 1983-10-05 | Smith Kline French Lab | Pharmaceutical compositions |
| DE3505609A1 (de) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
| FR2584713B1 (fr) * | 1985-07-11 | 1988-09-09 | Roussel Uclaf | Nouveaux derives de l'indole carboxamide, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant |
| JPH0629254B2 (ja) * | 1986-09-08 | 1994-04-20 | 帝国臓器製薬株式会社 | ピリダジノン誘導体 |
| NZ222843A (en) * | 1986-12-22 | 1989-10-27 | Ortho Pharma Corp | Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments |
| DE3734083A1 (de) * | 1987-10-08 | 1989-04-20 | Heumann Pharma Gmbh & Co | Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| NZ234087A (en) * | 1989-06-19 | 1991-08-27 | Teikoku Hormone Mfg Co Ltd | 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives |
| JPH03141264A (ja) * | 1989-08-10 | 1991-06-17 | Glaxo Inc | 強心活性およびベータ遮断活性を有するピリダジノン |
-
1989
- 1989-10-14 DE DE3934436A patent/DE3934436A1/de not_active Ceased
-
1990
- 1990-05-28 EP EP90110052A patent/EP0400519A1/fr not_active Withdrawn
- 1990-05-29 IL IL94556A patent/IL94556A0/xx unknown
- 1990-05-30 US US07/530,958 patent/US5135932A/en not_active Expired - Fee Related
- 1990-05-30 NZ NZ233875A patent/NZ233875A/xx unknown
- 1990-05-31 KR KR1019900007929A patent/KR910000660A/ko not_active Withdrawn
- 1990-05-31 HU HU903281A patent/HU206201B/hu not_active IP Right Cessation
- 1990-05-31 AU AU56127/90A patent/AU623262B2/en not_active Ceased
- 1990-05-31 NO NO90902411A patent/NO902411L/no unknown
- 1990-05-31 JP JP2143268A patent/JPH03236378A/ja active Pending
- 1990-05-31 CA CA002017957A patent/CA2017957A1/fr not_active Abandoned
- 1990-05-31 PT PT94213A patent/PT94213A/pt not_active Application Discontinuation
- 1990-06-01 FI FI902734A patent/FI902734A7/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT53885A (en) | 1990-12-28 |
| IL94556A0 (en) | 1991-03-10 |
| FI902734A0 (fi) | 1990-06-01 |
| US5135932A (en) | 1992-08-04 |
| EP0400519A1 (fr) | 1990-12-05 |
| CA2017957A1 (fr) | 1990-12-01 |
| FI902734A7 (fi) | 1990-12-02 |
| PT94213A (pt) | 1991-02-08 |
| NZ233875A (en) | 1991-10-25 |
| AU623262B2 (en) | 1992-05-07 |
| NO902411D0 (no) | 1990-05-31 |
| KR910000660A (ko) | 1991-01-29 |
| HU206201B (en) | 1992-09-28 |
| HU903281D0 (en) | 1990-10-28 |
| JPH03236378A (ja) | 1991-10-22 |
| AU5612790A (en) | 1990-12-06 |
| DE3934436A1 (de) | 1991-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO902411L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| JP4510372B2 (ja) | アシルフェニル尿素誘導体、その製造方法及び医薬としてのその使用 | |
| US4466972A (en) | Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them | |
| DE60003949T2 (de) | 5-aryl-1h-1,2,4 triazolverbindungen als cyclooxygenase -2 inhibitoren und dieseenthaltende pharmazeutische zusammensetzungen | |
| NO904839L (no) | Fremgangsmaate for fremstilling av benzoxazinderivater. | |
| JP4634144B2 (ja) | ニトロソ化プロトンポンプ阻害剤、組成物および使用方法 | |
| GB1573809A (en) | Basically substituted indole derivative and process for their manufacture | |
| NO970511L (no) | Nye substituerte oksazolidinoner | |
| NO900831L (no) | Fremgangsmaate for fremstilling av piperidinforbindelser. | |
| EP0233284A1 (fr) | Composes pharmaceutiques. | |
| NO170760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nafthalenderivater | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO163568C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| JPS54154766A (en) | Novel imidazole derivative*its manufacture and medicine containing said derivative and having antiiinflammatory and antiiallergic activity | |
| AU2005202553A1 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
| ATE124408T1 (de) | Heterozyklische aminderivate, deren herstellung und deren verwendung. | |
| EP0270093A3 (fr) | Dérivés de lactame, leurs procédé de préparation, compositions pharmaceutiques les contenant et leur application à la fabrication de médicaments à propriétés thérapeutiques | |
| MA21026A1 (fr) | Derives de 4-(aroylamino) piperidinebutanamide, et leur procede de preparation | |
| NO165195C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. | |
| ES2016305B3 (es) | Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso. | |
| NO165144C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av interne salter av aminopyridiniumhydroksidog deres tilsvarende salter. | |
| NO20013601L (no) | Nye morfolinobenzamidsalter | |
| NO883263D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater. | |
| SE8702119D0 (sv) | 3-(hydroxymethyl)-isoquinoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |